Reaction Details |
| Report a problem with these data |
Target | Neuromedin-K receptor |
---|
Ligand | BDBM50337407 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_728369 (CHEMBL1685145) |
---|
Ki | 3.6±n/a nM |
---|
Citation | Juhl, K; Hansen, T; Kehler, J; Khanzhin, NA; Nørgaard, MB; Ruhland, T; Larsen, DB; Jensen, KG; Steiniger-Brach, B; Nielsen, SM; Simonsen, KB Identification of a new series of non-peptidic NK3 receptor antagonists. Bioorg Med Chem Lett21:1498-501 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuromedin-K receptor |
---|
Name: | Neuromedin-K receptor |
Synonyms: | NK-3 receptor | NK-3R | NK3R | NK3R_HUMAN | NKR | Neurokinin 3 receptor | Neurokinin B receptor | Neurokinin-3 (NK-3) | Neuromedin-3 receptor (NK-3R) | Neuromedin-3 receptor (NK3) | Neuromedin-K receptor | Neuromedin-K receptor (NK-3 receptor) | Neuromedin-K receptor (NK3) | Neuromedin-K receptor(NK3R) | TAC3R | TACR3 | Tachykinin receptor 3 | Tachykinin receptor 3 (NK3) |
Type: | Enzyme |
Mol. Mass.: | 52221.96 |
Organism: | Homo sapiens (Human) |
Description: | P29371 |
Residue: | 465 |
Sequence: | MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGL
PVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVT
NYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIA
VDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEG
PKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKM
MIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLN
KRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADT
TRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
|
|
|
BDBM50337407 |
---|
n/a |
---|
Name | BDBM50337407 |
Synonyms: | CHEMBL1682672 | N1-(1-(((1R,2S)-2-(benzyl(methyl)carbamoyl)-2-(3,4-dichlorophenyl)cyclopropyl)methyl)-4-phenylpiperidin-4-yl)-N1-methyloxalamide |
Type | Small organic molecule |
Emp. Form. | C33H36Cl2N4O3 |
Mol. Mass. | 607.57 |
SMILES | CN(Cc1ccccc1)C(=O)[C@]1(C[C@H]1CN1CCC(CC1)(N(C)C(=O)C(N)=O)c1ccccc1)c1ccc(Cl)c(Cl)c1 |r| |
Structure |
|